Maresins Biopharma

Maresins Biopharma is a Barcelona-based biotechnology company specializing in the development of therapies derived from Specialized Pro-resolving Mediators (SPMs), with a primary focus on the Maresin family of bioactive lipids. The company's research is centered on harnessing the body's natural mechanisms for resolving inflammation to treat chronic conditions such as metabolic dysfunction-associated steatohepatitis (MASH) and other inflammatory diseases. By developing stable analogs of Maresin-1 and Maresin-2, the company aims to provide potent pro-resolving effects without the risks associated with traditional immunosuppression. Maresins Biopharma operates as a spin-off from the University of Barcelona and IDIBAPS, leveraging deep expertise in lipidomics and inflammatory resolution. Their pipeline includes several pre-clinical programs targeting metabolic and systemic inflammatory disorders. The company seeks to address the high unmet need in chronic inflammatory diseases through a novel resolution-based approach.